A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO-idel)

dc.contributor.authorIslam, A.
dc.date.accessioned2023-06-07T14:19:25Z
dc.date.available2023-06-07T14:19:25Z
dc.date.issued2021
dc.identifier.citationEyre, T. A., Preston, G., Kagdi, H., Islam, A., Nicholson, T., Smith, H. W., Cursley, A. P., Ramroth, H., Xing, G., Gu, L., Rajakumaraswamy, N. & Fegan, C. 2021. A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO-idel). British Journal of Haematology, 194, (1) 69-77.
dc.identifier.doihttps://dx.doi.org/10.1111/bjh.17475
dc.identifier.issn0007-1048
dc.identifier.issn1365-2141
dc.identifier.journalBritish Journal of Haematology
dc.identifier.urihttps://hdl.handle.net/20.500.14265/3239
dc.language.isoEnglish
dc.publisherJohn Wiley and Sons Ltd
dc.source.issue1
dc.source.pages69-77
dc.source.volume194
dc.titleA retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO-idel)
dc.typeArticle
Files